Bioavailability Enhancement is a process used in pharmaceutical manufacturing to improve the absorption of a drug into the body. This is done by altering the drug's physical or chemical properties, such as its solubility, dissolution rate, or permeability. This can be achieved through various techniques, such as particle size reduction, salt formation, and prodrug design. Bioavailability Enhancement can improve the efficacy of a drug, reduce its side effects, and increase its shelf life. Companies in the Bioavailability Enhancement market include BASF, Merck, Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
